Audit of the new GMS contract Quality and Outcomes Framework: Raising standards in CHD

British Journal of Cardiology

Volumn 14, Issue 2, 2007, Pages 117-119

  McCarlie, Janet ^a   Reid, Elisabet ^b   Brady, Adrian J B ^c  

^a Ayrshire Central Hospital   (United Kingdom)

^b CROSSHOUSE HOSPITAL   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coronary heart disease; New GMS contract; Primary care; Quality and outcomes framework

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CONTRACT; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL AUDIT; MEDICAL SERVICE; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIMARY HEALTH CARE; QUALITY CONTROL; REVIEW; SECONDARY PREVENTION;

EID: 34248530098     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Department of Health. Investing in general practice: the new General Medical Services contract. DoH, December 2003. (http://www.dh.gov.uk/) accessed 2/3/05.
2. ISD Scotland. Scottish Health Statistics. Coronary Heart Disease and Stroke'. ISD, October 2004. (http://www.isdscotland.org/isd/files/ m1.xls) accessed 2/3/05.